Cargando…
CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy
BACKGROUND: The ubiquity of protein-protein interactions in biological signaling offers ample opportunities for therapeutic intervention. We previously identified a peptide, designated CBD3, that suppressed inflammatory and neuropathic behavioral hypersensitivity in rodents by inhibiting the ability...
Autores principales: | Piekarz, Andrew D, Due, Michael R, Khanna, May, Wang, Bo, Ripsch, Matthew S, Wang, Ruizhong, Meroueh, Samy O, Vasko, Michael R, White, Fletcher A, Khanna, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502107/ https://www.ncbi.nlm.nih.gov/pubmed/22828369 http://dx.doi.org/10.1186/1744-8069-8-54 |
Ejemplares similares
-
CRMP2 and voltage-gated ion channels: potential roles in neuropathic pain
por: Chew, Lindsey A., et al.
Publicado: (2018) -
The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain
por: Feldman, Polina, et al.
Publicado: (2012) -
Neuroexcitatory effects of morphine-3-glucuronide are dependent on Toll-like receptor 4 signaling
por: Due, Michael R, et al.
Publicado: (2012) -
Chemical shift perturbation mapping of the Ubc9-CRMP2 interface identifies a pocket in CRMP2 amenable for allosteric modulation of Nav1.7 channels
por: François-Moutal, Liberty, et al.
Publicado: (2018) -
Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief
por: Moutal, Aubin, et al.
Publicado: (2019)